Asthma and Allergy Foundation of America Challenges Patients and Caregivers to
'Get Smart About Asthma'
New Online Resource Deepens Understanding of Large and Small Airway
Inflammation in Asthma
WASHINGTON, Jan 24, 2013
WASHINGTON, Jan 24, 2013 /PRNewswire/ -- The Asthma and Allergy Foundation of
America (AAFA) and Teva Respiratory announced today the launch of Get Smart
About Asthma, a comprehensive online asthma management resource that takes a
unique look at the underlying cause of asthma – inflammation. The website –
www.GetSmartAboutAsthma.com – aims to increase understanding of how
inflammation in both the large and small airways plays an important role in
asthma persistence or severity, in addition to providing tools and educational
resources to help minimize and manage the symptoms associated with persistent
asthma. Designed for the well-informed asthma patient or caregiver, the
website features important information about the latest research in asthma.
The site also provides downloadable toolkits and discussion guides to help
people with asthma maintain open lines of communication with their healthcare
"Many of the 25 million Americans who suffer from asthma may know the basics
about their condition, but GetSmartAboutAsthma.com will expand their
knowledge even more," said Dr. LeRoy Graham, pediatric pulmonologist at
Georgia Pediatric Pulmonology Associates. "Asthma is a life-long condition
that, if not managed properly, can also be life-threatening. It is important
for patients to have a thorough understanding about their asthma, including
how to manage chronic inflammation on a daily basis."
People with persistent asthma can develop ongoing inflammation in the large
and small airways of the lungs. Asthma symptoms due to inflammation can be
different depending on the severity, but common symptoms can include coughing,
wheezing, trouble breathing and tightness in the chest. ^ Despite chronic
inflammation of the airways, people with persistent asthma may not always
experience these outward symptoms of asthma. For these patients, current
treatment guidelines recommend a daily maintenance therapy to help prevent
inflammation, manage symptoms and control asthma. When asthma is under
control, patients lessen the chance of an asthma attack and can remain active
without having asthma symptoms and worry less about emergency visits or stays
at the hospital.
"Having worked for close to 60 years with patients living with asthma, AAFA
understands how important it is for them to take a proactive approach to fully
educating themselves about their condition and the proper ways to effectively
manage and control their asthma," said Bill McLin, President and CEO of AAFA.
"Our goal is to encourage patients with asthma and their caregivers to be
their own advocates and to gain access to much-needed tools and resources
through educational platforms such as Get Smart About Asthma."
Teva Respiratory is a corporate sponsor of www.GetSmartAboutAsthma.com.
Asthma is a chronic (long-term) disease of inflammation of both the large and
small airways of the lung, characterized by symptoms including wheezing and
coughing. Asthma may cause recurring periods of wheezing (a whistling sound
when you breathe), chest tightness, shortness of breath, and coughing that
often occur at night or early in the morning. ^ Without appropriate
treatment, asthma symptoms may persist and result in an asthma attack, which
can lead to hospitalization and even death.
About Asthma and Allergy Foundation of America
The Asthma and Allergy Foundation of America (AAFA) is a not-for-profit
organization founded in 1953 that serves as the leading patient organization
for people with asthma and allergies, and the oldest asthma and allergy
patient group in the world. AAFA is dedicated to improving the quality of
life for people with asthma and allergic diseases through education, advocacy
and research. AAFA provides practical information, community-based services
and support to people through a network of regional chapters, support groups
and other local partners around the U.S. AAFA develops health education,
organizes state and national advocacy efforts and funds research to find
better treatments and cures.
About Teva Respiratory
Teva Respiratory is the U.S.-based respiratory subsidiary of Teva
Pharmaceutical Industries Ltd. (NYSE: TEVA). Teva Pharmaceutical Industries
Ltd. is a leading global pharmaceutical company, committed to increasing
access to high-quality healthcare by developing, producing and marketing
affordable generic drugs as well as innovative and specialty pharmaceuticals
and active pharmaceutical ingredients. Headquartered in Israel, Teva is the
world's leading generic drug maker, with a global product portfolio of more
than 1,000 molecules and a direct presence in about 60 countries.
SOURCE The Asthma and Allergy Foundation of America
Contact: Mike Tringale, Vice President External Affairs, Asthma and Allergy
Foundation of America, +1-202-466-7643 ext. 272, email@example.com
Press spacebar to pause and continue. Press esc to stop.